Each year 750,000 Americans suffer an acute ischemic stroke yet less than five percent receive pharmacologic treatment because of risks associated with the current therapy. New Mexico-based Zocere has a “brain protecting” drug it believes has the potential to be the first neuroprotectant on the market, and will be pitching the idea to investors at the BIO Investor Forum October 7 and 8 in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
